
Covid-19 antibody treatments work, but they're 'not the path out of this pandemic'
CNN
When Texas Gov. Greg Abbott announced Tuesday that had tested postiive for Covid-19, his office shared that he was treated with a therapy not yet approved by the US Food and Drug Administration, but one of the few shown to be effective against the virus: monoclonal antibodies.
Monoclonal antibodies such as those made by Regeneron and GlaxoSmithKline won't work for every Covid-19 patient; mAbs, as they are known, are only available for people age 12 and older and who aren't hospitalized or severely ill. Regeneron's therapy can also be used for some people who know they were exposed to the virus, but don't yet have a positive test. That protection doesn't last long, though, and it's not a replacement for the vaccine.More Related News

President Donald Trump issued a stark threat to defense contracting companies on Wednesday, saying he would seek to limit stock buybacks and executive salaries unless they improve their delivery of weapons systems to the US military hours before saying he’d decided to substantially increase the defense budget.












